Long-acting buprenorphine vs. naltrexone opioid treatments in CJS']JS-involved adults (EXIT-CJS']JS)

被引:16
作者
Waddell, Elizabeth Needham [1 ,2 ]
Springer, Sandra A. [3 ]
Marsch, Lisa A. [3 ]
Farabee, David [4 ]
Schwartz, Robert P. [5 ]
Nyaku, Amesika [6 ]
Reeves, Rusty [7 ]
Goldfeld, Keith [4 ]
McDonald, Ryan D. [4 ]
Malone, Mia [5 ]
Cheng, Anna [5 ]
Saunders, Elizabeth C. [3 ]
Monico, Laura [5 ]
Gryczynski, Jan [5 ]
Bell, Kathleen [3 ]
Harding, Kasey [8 ]
Violette, Sandra [9 ]
Groblewski, Thomas [10 ]
Martin, Wendy [11 ]
Talon, Kasey [11 ]
Beckwith, Nicole [11 ]
Suchocki, Andrew [12 ]
Torralva, Randy [13 ]
Wisdom, Jennifer P. [13 ]
Lee, Joshua D. [4 ]
机构
[1] Oregon Hlth & Sci Univ, Sch Publ Hlth, Portland, OR 97201 USA
[2] Oregon Hlth & Sci Univ, OHSU Sch Med, Portland, OR 97201 USA
[3] Dartmouth Coll, Hanover, NH 03755 USA
[4] NYU Grossman SOM, New York, NY 10016 USA
[5] Friends Res Inst, Hollywood, CA USA
[6] State Univ New Jersey, New Jersey Med Sch, New Brunswick, NJ USA
[7] Rutgers Univ Correct Hlth Care, Rutgers Robert Wood Johnson Med Sch, New Brunswick, NJ USA
[8] Community Hlth Ctr Inc, Middletown, CT USA
[9] Connecticut Dept Correct, Wethersfield, CT USA
[10] New Hampshire Dept Correct, Concord, NH USA
[11] RD Better Life, Somersworth, NH USA
[12] Clackamas Cty Hlth Ctr, Sunnyside, OR USA
[13] CODA Inc, Portland, OR USA
关键词
Opioid use disorder; Medication treatment; Buprenorphine; Naltrexone; Injection; Criminal justice; EXTENDED-RELEASE NALTREXONE; ABUSE TREATMENT; DOUBLE-BLIND; NALOXONE; INCARCERATION; MULTICENTER; DEPENDENCE; RELAPSE; HIV;
D O I
10.1016/j.jsat.2021.108389
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
The EXIT-CJS (N = 1005) multisite open-label randomized controlled trial will compare retention and effectiveness of extended-release buprenorphine (XR-B) vs. extended-release naltrexone (XR-NTX) to treat opioid use disorder (OUD) among criminal justice system (CJS)-involved adults in six U.S. locales (New Jersey, New York City, Delaware, Oregon, Connecticut, and New Hampshire). With a pragmatic, noninferiority design, this study hypothesizes that XR-B (n = 335) will be noninferior to XR-NTX (n = 335) in retention-in-study-medication treatment (the primary outcome), self-reported opioid use, opioid-positive urine samples, opioid overdose events, and CJS recidivism. In addition, persons with OUD not eligible or interested in the RCT will be recruited into an enhanced treatment as usual arm (n = 335) to examine usual care outcomes in a quasi-experimental observational cohort.
引用
收藏
页数:8
相关论文
共 26 条
[1]  
American Psychiatric Association, 2022, Diagnostic and statistical manual of mental disorders, DOI DOI 10.1176/APPI.BOOKS.9780890425596
[2]  
[Anonymous], 2017, SUBL FULL PRESCR INF
[3]   Mortality After Prison Release: Opioid Overdose and Other Causes of Death, Risk Factors, and Time Trends From 1999 to 2009 [J].
Binswanger, Ingrid A. ;
Blatchford, Patrick J. ;
Mueller, Shane R. ;
Stern, Marc F. .
ANNALS OF INTERNAL MEDICINE, 2013, 159 (09) :592-600
[4]   A Literature Review Examining Primary Outcomes of Medication Treatment Studies for Opioid Use Disorder: What Outcome Should Be Used to Measure Opioid Treatment Success? [J].
Biondi, Breanne E. ;
Zheng, Xiaoying ;
Frank, Cynthia A. ;
Petrakis, Ismene ;
Springer, Sandra A. .
AMERICAN JOURNAL ON ADDICTIONS, 2020, 29 (04) :249-267
[5]   METHADONE TREATMENT OF RANDOMLY SELECTED CRIMINAL ADDICTS [J].
DOLE, VP ;
ROBINSON, JW ;
ORRACA, J ;
TOWNS, E ;
SEARCY, P ;
CAINE, E .
NEW ENGLAND JOURNAL OF MEDICINE, 1969, 280 (25) :1372-&
[6]   The timeline followback reports of psychoactive substance use by drug-abusing patients: Psychometric properties [J].
Fals-Stewart, W ;
O'Farrell, TJ ;
Freitas, TT ;
McFarlin, SK ;
Rutigliano, P .
JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 2000, 68 (01) :134-144
[7]   A randomized comparison of extended-release naltrexone with or without patient navigation vs enhanced treatment-as-usual for incarcerated adults with opioid use disorder [J].
Farabee, David ;
Condon, Timothy ;
Hallgren, Kevin A. ;
McCrady, Barbara .
JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2020, 117
[8]   Medication-Assisted Treatment in Criminal Justice Agencies Affiliated with the Criminal Justice-Drug Abuse Treatment Studies (CJ-DATS): Availability, Barriers, and Intentions [J].
Friedmann, Peter D. ;
Hoskinson, Randall, Jr. ;
Gordon, Michael ;
Schwartz, Robert ;
Kinlock, Timothy ;
Knight, Kevin ;
Flynn, Patrick M. ;
Welsh, Wayne N. ;
Stein, Lynda A. R. ;
Sacks, Stanley ;
O'Connell, Daniel J. ;
Knudsen, Hannah K. ;
Shafer, Michael S. ;
Hall, Elizabeth ;
Frisman, Linda K. .
SUBSTANCE ABUSE, 2012, 33 (01) :9-18
[9]   Buprenorphine-naloxone treatment for pre-release opioid-dependent inmates in Puerto Rico [J].
Garcia, Carmen Albizu ;
Correa, Glorimar Caraballo ;
Viver, Adriana D. Hernandez ;
Kinlock, Timothy W. ;
Gordon, Michael S. ;
Avila, Cristobal Antron ;
Reyes, Ivette Colon ;
Schwartz, Robert P. .
JOURNAL OF ADDICTION MEDICINE, 2007, 1 (03) :126-132
[10]   Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial [J].
Haight, Barbara R. ;
Learned, Susan M. ;
Laffont, Celine M. ;
Fudala, Paul J. ;
Zhao, Yue ;
Garofalo, Amanda S. ;
Greenwald, Mark K. ;
Nadipelli, Vijay R. ;
Ling, Walter ;
Heidbreder, Christian ;
Andersen, James L. ;
Bailey, Genie L. ;
Bartley, Scott Robert ;
Biunno, Michael J. ;
Boyett, Brent ;
Carr, Jesse M. ;
Cifuentes, Eduardo ;
Duarte-Sckell, Sandra Daniela ;
Dueno, Otto R. ;
Harrison, Boyde J. ;
Hassman, David R. ;
Hoffman, Kent Steven ;
Isacesu, Valentin ;
Ishaque, Saleem ;
Kakar, Rishi ;
Kampman, Kyle ;
Knapp, Richard D. ;
Konis, George ;
Kunovac, Jelena ;
Kwentus, Joseph A. ;
Levinson, Lawrence S. ;
Malhotra, Shishuka ;
Mehra, Vishaal ;
Mofsen, Ricky Stuart ;
Peyton, Marvin Lane ;
Pujari, Gita G. ;
Ranjan, Rakesh ;
Rutrick, Daniel ;
Seal, Gregory ;
Segal, Scott Daniel ;
Shiwach, Rajinder ;
Thomas, Haydn Mikel ;
Ventre, Peter Paul ;
Vijapura, Amit K. ;
Walling, David P. ;
Wiest, Katharina L. .
LANCET, 2019, 393 (10173) :778-790